Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Depreciation & Amortization (CF) (2016 - 2025)

STRATA Skin Sciences (SSKN) has disclosed Depreciation & Amortization (CF) for 14 consecutive years, with $821000.0 as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) fell 33.25% to $821000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.1 million through Dec 2025, down 17.01% year-over-year, with the annual reading at $4.1 million for FY2025, 17.01% down from the prior year.
  • Depreciation & Amortization (CF) hit $821000.0 in Q4 2025 for STRATA Skin Sciences, down from $864000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $2.2 million in Q4 2021 to a low of $481000.0 in Q1 2021.
  • Historically, Depreciation & Amortization (CF) has averaged $1.2 million across 5 years, with a median of $1.2 million in 2024.
  • Biggest five-year swings in Depreciation & Amortization (CF): crashed 53.66% in 2021 and later surged 174.64% in 2022.
  • Year by year, Depreciation & Amortization (CF) stood at $2.2 million in 2021, then plummeted by 38.8% to $1.3 million in 2022, then dropped by 3.25% to $1.3 million in 2023, then fell by 3.83% to $1.2 million in 2024, then tumbled by 33.25% to $821000.0 in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for SSKN at $821000.0 in Q4 2025, $864000.0 in Q3 2025, and $1.2 million in Q2 2025.